| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/07/2008 | CA2659689A1 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents |
| 02/07/2008 | CA2658799A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/07/2008 | CA2652220A1 Adhesive preparation comprising methyl salicylate for percutaneous absorption |
| 02/06/2008 | EP1884510A1 N-substituted phenylacetamide derivative and pharmaceutical composition comprising the same |
| 02/06/2008 | EP1884240A1 Pharmaceutical for prevention or treatment of bone metabolic disease |
| 02/06/2008 | EP1883636A1 Substituted piperidine antagonist of hi receptor to be used for the treatment of rhinitis |
| 02/06/2008 | EP1883632A1 Vanilloid receptor ligands and their use in treatments |
| 02/06/2008 | EP1883620A1 ß-AMINO ACID DERIVATIVES |
| 02/06/2008 | EP1883409A2 Phospholipids for use in the treatment of an allergic inflammatory condition |
| 02/06/2008 | EP1883404A1 P38 inhibitors and methods of use thereof |
| 02/06/2008 | EP1339712B1 3-substituted quinuclidines and their use as nicotinic agonists |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | EP0773939B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 02/06/2008 | CN101120005A Thiazolopyrimidine compounds for the modulation of chemokine receptor activity |
| 02/06/2008 | CN101119995A Non steroidal glucocorticoid receptor modulators |
| 02/06/2008 | CN101119730A Ointment |
| 02/06/2008 | CN101119716A External plaster containing flurbiprofen |
| 02/06/2008 | CN101116683A Medicine for treating arthritis |
| 02/06/2008 | CN101116681A Rheum fever allaying tables and method for preparing the same |
| 02/06/2008 | CN101116676A Method for preparing compound milettia reticulata particles |
| 02/06/2008 | CN101116662A Application of sophocarpine in the preparation of medicine for treating adenovirus-caused inflammation |
| 02/06/2008 | CN101116524A Cassia twig astragalus root beverage |
| 02/06/2008 | CN101116523A Small red bean beverage |
| 02/06/2008 | CN101116475A Method for preparing golden carbendazim feed additive |
| 02/06/2008 | CN101116467A Heat-clearing fire-lowing tea and method for preparing the same |
| 02/06/2008 | CN100366618C Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 02/06/2008 | CN100366293C Inhibitors of complement activation |
| 02/06/2008 | CN100366275C Method for controlling quality of Yunnan red tablet |
| 02/06/2008 | CN100366264C Cornel extract and use thereof |
| 02/06/2008 | CN100366260C Astragalus glycoside fatty emulsion and its preparation technology |
| 02/06/2008 | CN100366259C Application of general saponin of gen-seng fruit in the preparation process of myocarditis treating medicine |
| 02/06/2008 | CN100366240C Ultraviolet-shielding type patch |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326729 CXCR1 and CXCR2 chemokine antagonists |
| 02/05/2008 | US7326727 Furanthiazole derivatives as heparanase inhibitors |
| 02/05/2008 | US7326723 Autoimmune disease; antiinflammatory agents |
| 02/05/2008 | US7326722 N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy |
| 02/05/2008 | US7326720 Phenyl- and pyridylpiperidines with TNF activity |
| 02/05/2008 | US7326715 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | US7326682 Conotoxin peptides |
| 02/05/2008 | US7326681 Methods for producing modified glycoproteins |
| 02/05/2008 | US7326414 Monoclonal antibody that specifically binds macrophage colony stimulating factor; rheumatoid arthritis |
| 02/05/2008 | US7326411 Use of amino-terminally truncated RANTES to inhibit HIV viral replication |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2349227C Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 02/05/2008 | CA2264065C Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 01/31/2008 | WO2008014286A1 Vinyl phosphonate lysophosphatidic acid receptor antagonists |
| 01/31/2008 | WO2008013197A1 Spherical crude granule and method for production thereof |
| 01/31/2008 | WO2008013082A1 Galectin 9-polymer conjugate |
| 01/31/2008 | WO2008012563A2 Use of cdk inhibitors for the treatment of granulocyte mediated disorders |
| 01/31/2008 | WO2008012418A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/31/2008 | WO2008012361A2 Dimethano-[1,3] dioxocino [6,5-d] pyrimidine-spiro derivatives of tetrodotoxin, process for their synthesis and uses thereof in the treatment of pain |
| 01/31/2008 | WO2008012338A2 Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions |
| 01/31/2008 | WO2008012326A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/31/2008 | WO2007131310B1 Anti-inflammatory and analgesic pharmaceutical composition containing safrole n-acylhydrazone derivatives, use, and method of preparation |
| 01/31/2008 | WO2007120574A3 Diaryl substituted alkanes |
| 01/31/2008 | WO2007094669A3 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation |
| 01/31/2008 | WO2007061912A3 High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith |
| 01/31/2008 | WO2006110814A3 Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| 01/31/2008 | US20080027133 Use of chromen-4-one derivatives |
| 01/31/2008 | US20080027123 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating erythema nodosum leprosum in leprosy, rhematoid spondylitis, hepatitis or congestive heart failure |
| 01/31/2008 | US20080027099 Bicyclic heteroaryl inhibitors of pde4 |
| 01/31/2008 | US20080027090 N-5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinolin-2-yl-3,3-dimethylbutanamide; for treating cardiovascular disorders, nervous system disorders e.g epilepsy, episodic ataxia type 1, paroxysmal dyskinesia, neurodegenerative spincerebrallar ataxia, Parkinson's disease |
| 01/31/2008 | US20080027081 Therapeutic compounds |
| 01/31/2008 | US20080027070 2-amino--5-substituted pyrimidine inhibitors |
| 01/31/2008 | US20080027067 Heterocyclic derivatives as modulators of ion channels |
| 01/31/2008 | US20080027062 2-amino-4-N-cyclohexylmethylamino-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-pteridine; treatment of pathological blood pressure decreases, such as occur in septic or hemorrhagic shock, in tumor or cancer therapy with cytokines, liver cirrhosis; ulcerative colitis; NO synthase inhibitor |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080027036 S1P receptor modulating compounds and use thereof |
| 01/31/2008 | US20080027032 Combinations comprising cox-2 inhibitors and aspirin |
| 01/31/2008 | US20080027031 Retinoids and Related Compounds for the Treatment of Neuroinflammatory Conditions, Diseases and Disorders |
| 01/31/2008 | US20080027029 Cold menthol receptor-1 antagonists |
| 01/31/2008 | US20080027019 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 01/31/2008 | US20080027000 APO-A-I Regulation of T-Cell Signaling |
| 01/31/2008 | US20080026998 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 01/31/2008 | US20080026984 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 01/31/2008 | US20080026371 Protein C And Endothelial Protein C Receptor Polymorphisms As Indicators Of Subject Outcome |
| 01/31/2008 | US20080026058 Methods for treating and preventing mucositis |
| 01/31/2008 | US20080026054 Novel anelgesic combination |
| 01/31/2008 | US20080025986 Methods of Treating Tnf-Mediated Disorders |
| 01/31/2008 | US20080025971 Antibody comprising a human heavy chain framework sequence, three heavy chain hypervariable region sequences and three light chain hypervariable region sequences; modulating biological activity of integrins containing the beta7 subunit |
| 01/31/2008 | DE102006033109A1 Substituierte Heteroaryl-Derivate Substituted heteroaryl derivatives |
| 01/31/2008 | CA2842219A1 Inhibition of marcks-mediated degranulation by marcks n-terminal peptides in treating inflammation |
| 01/31/2008 | CA2658314A1 Parenteral preparations of gi-safer phospholipid-associated anti-inflammatories and methods of preparation and use |
| 01/31/2008 | CA2657200A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/31/2008 | CA2656716A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 01/30/2008 | EP1882695A2 Pharmaceutically active compounds and methods of use thereof |
| 01/30/2008 | EP1882692A1 Dimethano-[1,3]dioxocino[6,5-D]pyrimidine-spiro derivatives of tetrodotoxin, process for their synthesis and uses thereof in the treatment of pain |
| 01/30/2008 | EP1882687A1 Heterocyclic compounds useful as vanilloid receptor antagonists and pharmaceutical compositions containing the same |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1881988A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1) |
| 01/30/2008 | EP1881982A1 Imidazolone phenylalanine derivatives as vla-4 antagonists |
| 01/30/2008 | EP1881968A2 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds |
| 01/30/2008 | EP1881967A1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics |
| 01/30/2008 | EP1881950A1 New compounds i |
| 01/30/2008 | EP1881832A2 Use of flibanserin in the treatment of chronic pain |
| 01/30/2008 | EP1881826A1 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2) |